Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest-growing industries. We are a publicly traded life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. We are passionate about the promise of genomics to improve human health and are committed to making it a reality. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact in a rapidly expanding company. Innovation, continuous learning, multi-disciplinary collaboration and diversity of thought are pillars of our culture.
We foster a dynamic, fast paced, result oriented environment where we offer employees the opportunity to make a significant impact in a rapidly expanding company. Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest growing industries. We are located in the center of the Biotech hub on the Torrey Mesa close to the Pacific Ocean and next door to prestigious institutions like the Salk Institute, Scripps, Sanford Burnham, and UCSD. We offer free gym membership, 401K plan, competitive health benefits, flexible vacation, and equity incentives, so you can grow as the company grows. We are working to accelerate genomics for the advancement of science and medicine and are passionate about the potential of genomics for improving human health.
We foster a dynamic, fast paced, result oriented environment where we offer employees the opportunity to make a significant impact in a rapidly expanding company. Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest growing industries. We are located in the center of the Biotech hub on the Torrey Mesa close to the Pacific Ocean and next door to prestigious institutions like the Salk Institute, Scripps, Sanford Burnham, and UCSD. We offer free gym membership, 401K plan, competitive health benefits, flexible vacation, and equity incentives, so you can grow as the company grows. We are working to accelerate genomics for the advancement of science and medicine and are passionate about the potential of genomics for improving human health.
Location: Mali, Ségou
Employees: 51-200
Founded date: 2016
Investors 7
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | S32 | s32.com |
| - | F-Prime Ca... | fprimecapi... |
| - | Section 32 | section32.... |
| - | Perceptive... | perceptive... |
| - | Eight Road... | eightroads... |
Mentions in press and media 5
| Date | Title | Description |
| 04.03.2024 | Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 | SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced tha... |
| 07.02.2023 | Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future | MäNNEDORF, SWITZERLAND, February 7, 2023 /EINPresswire.com/ -- Tecan has partnered with Singular Genomics to use the turnkey MagicPrep™ NGS system* to create sequencing-ready libraries for the G4™ Sequencing Platform. The agreement will bri... |
| 31.03.2022 | Singular Genomics Marks First Year as Public Company | The Singular Genomics G4 Instrument launched in December 2021. (Photo Courtesy of Singular Genomics) Six years ago, investor Andrew Spaventa and former Illumina CSO David Barker decided to invest in Eli Glezer’s idea to start a company that... |
| 16.12.2021 | Singular Genomics : Launches the G4 Sequencing Platform - Form 8-K | Singular Genomics Launches the G4 Sequencing Platform - Next-generation sequencing platform will provide up to three times more data output per hour than other benchtop instruments, while offering flexible run capacity - La Jolla, CA, Decem... |
| 07.05.2021 | Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO | - |